Company intelligence
LeagueMed
About LeagueMed
Invest in the future of healthcare. Make a difference. Share the benefits. LeagueMed enables healthcare professionals to leverage their education, experience and financial resources to fund innovation and pursue opportunities for portfolio diversification and wealth creation. We bring together innovative companies, the broad spectrum of healthcare professionals, and everyone interested in the opportunity to invest in new technologies that save lives, improve patient outcomes, and elevate the quality of life. We provide access to a carefully researched pipeline of private investments for as little as $10K. Join for Free. Members get notified immediately about new deals on the LeagueMed platform. Additional benefits include Continuing Medical Education and other financial products for healthcare professionals. Make your private market investments count by joining LeagueMed. The investment opportunities featured on LeagueMed.com are offered through our affiliate, League Capital Markets LLC, an SEC registered, FINRA member broker dealer.
Verified activity
Signals from LeagueMed
5 published signals
Legal & Regulatory
LeagueMed acquired 15 issued patents and 10 pending patents covering the attachment mechanism, the case, and the safety systems around an auto-injector phone EpiPen.
Reported by LeagueMed
Strategy & Corporate Development
LeagueMed published the LeagueMed Weekly Digital Health and MedTech Innovation Brief noting that Congress moved to extend Medicare telehealth through 2027 and hospital-at-home through 2030.
Reported by LeagueMed
Strategy & Corporate Development
LeagueMed published the LeagueMed Weekly Digital Health and MedTech Innovation Brief noting that Cardinal Health made a $5.7 billion move into home-based diabetes care.
Reported by LeagueMed
Strategy & Corporate Development
LeagueMed published the LeagueMed Weekly Digital Health and MedTech Innovation Brief highlighting that automated prior authorization and explainable AI advanced inside real clinical workflows.
Reported by LeagueMed
Research & Knowledge
LeagueMed published the LeagueMed Weekly Digital Health and MedTech Innovation Brief highlighting the FDA cleared the first standalone robotic blood-draw device in a regulatory-heavy stretch.
Reported by LeagueMed